The CRS and local collaborators have been awarded a new T32 grant! 12/28/2020
Great news – the Center for Resuscitation Science along with collaborators from across Boston-area hospitals have been awarded a T32 training grant in Resuscitation Science Research. More details to follow shortly and our fellowship training portion of the website will be updated shortly. Congrats to all involved and look forward to stating this exciting NIH-funded training program.
Reflecting on this Year’s ReSS! 12.16.2019
Michael Donnino and Won Young Kim
Abstract Acceptances to AHA ReSS Conference 9/11/2019
Congratulations to our team members who have accepted abstracts for the 2019 AHA ReSS Conference in November 2019!
Anne Grossestreuer – Missing SOFA score data in cardiac arrest research studies: a scoping review and it was accepted as a poster. It is a scoping review of the missing SOFA score data when SOFA is used as an exposure or outcome in cardiac arrest research studies. Co-authors are Ari Moskowtiz, Mike Donnino, Tuyen Yankama, and Long Ngo.
Catherine Ross – Effect of Guideline Changes on Drug Administration in Pediatric In-hospital Cardiac Arrest. A WTG-R study with co-authors Ari Moskowitz, Tuyen T. Yankama, Mathias J. Holmberg, Lars W. Andersen, Anne V. Grossestreuer, Amanda O’Halloran, Monica E. Kleinman, and Michael W. Donnino.
Kate Berg – Trends over time in median CPR duration in non survivors was accepted for oral presentation.
Mahmoud Issa – Lactate/Hypotension for IHCA accepted as a poster. It is a scoping mortality prediction by lactate level and vasopressors use post ROSC. Co-authors include Het Patel, Anne Grossestreuer, Tuyen Yankama, Lethu Ntshinga, Amin Coker, and Kate Berg.
How do you think about new hypotension in patients admitted to the ICU for pulmonary embolism? New vasopressor need is very rare (2.7%) and often related to bleeding. Think twice before pushing thrombolytics! 8/22/2019
How do you think about new hypotension in patients admitted to the ICU for pulmonary embolism? New vasopressor need is very rare (2.7%) and often related to bleeding. Think twice before pushing thrombolytics!